你即將離開本站

並前往https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-high-risk-early-stage-triple-negative-breast-cancer

FDA approves pembrolizumab for high-risk early-stage triple ...

On July 26, 2021, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for high-risk, early-stage, triple-negative breast cancer (TNBC) ...

確定！ 回上一頁

查詢 「July 26」的人也找了：

  1. July 26
    2.
  2. July 27
    3.
  3. July 30
    4.
  4. July 25
    5.
  5. July 28
    6.
  6. July wiki
    7.
  7. July 29
    8.
  8. Aug 3
    9.